Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01534923 · ClinicalTrials.gov registry record
Doctor-Patient Communication About Colorectal Cancer Screening
A clinical trial of Colorectal Cancer Screening, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 76
- Enrollment target
- 2
- Study locations
NCT01534923 is a study of Colorectal Cancer Screening that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 76 participants, below the 5,879-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT01534923, a study of Colorectal Cancer Screening, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 76 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to learn more about doctor-patient communication about colon cancer screening. This study will also look to see if there are differences in those who get colon cancer screening based on the discussion the doctor had with the patient.
Conditions Studied
Interventions
- BEHAVIORAL surveys
Study Locations (2)
New York
- Albert Einstein College of Medicine - The Bronx
- Hhc, Gun Hill and Tremont - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2012-02-07 |
| Est. Completion | 2019-12-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01534923
The ClinicalTrials.gov registry entry for NCT01534923 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,879-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (99% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colorectal Cancer Screening appearing as the primary indexed condition, and to 1 intervention - of which surveys is the first listed.
NCT01534923 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01534923 about?
NCT01534923 is a clinical study titled "Doctor-Patient Communication About Colorectal Cancer Screening". The purpose of this study is to learn more about doctor-patient communication about colon cancer screening. This study will also look to see if there are differences in those who get colon cancer screening based on the discussion the doctor had with the patient.
What is the current status of trial NCT01534923?
This trial is currently completed. The enrollment target is 76 participants. The study started on 2012-02-07. Estimated completion is 2019-12-26.
What conditions does trial NCT01534923 study?
This clinical trial studies the following conditions: Colorectal Cancer Screening.
What interventions are being tested in trial NCT01534923?
The interventions under investigation include: surveys (BEHAVIORAL).
Who is sponsoring clinical trial NCT01534923?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01534923 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Protect Your Colon™ on CRC Screening
RECRUITING · NA
-
Cleansing Options in Out-Patient Setting to Improve Tolerance (COOP SIT) Trial
RECRUITING · Phase 4
-
Use of a Colorectal Cancer Screening Decision Support Tool in Primary Care
RECRUITING · NA
-
A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
RECRUITING
-
Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening
RECRUITING · NA
-
Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.